4.4 Review

Pharmacogenetic approaches to the treatment of alcohol addiction

Journal

NATURE REVIEWS NEUROSCIENCE
Volume 12, Issue 11, Pages 670-684

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrn3110

Keywords

-

Categories

Funding

  1. US National Institute on Alcohol Abuse and Alcoholism
  2. US National Institutes of Health (NIH) [P20-DA-025995, R01-DA-025201, P60-DA 05186]
  3. NIH [P60-DA-005186-23, 5-P50-DA-012756-11, R01-DA-024553, R01-AA017164-2]

Ask authors/readers for more resources

Addictive disorders are partly heritable, chronic, relapsing conditions that account for a tremendous disease burden. Currently available addiction pharmacotherapies are only moderately successful, continue to be viewed with considerable scepticism outside the scientific community and have not become widely adopted as treatments. More effective medical treatments are needed to transform addiction treatment and address currently unmet medical needs. Emerging evidence from alcoholism research suggests that no single advance can be expected to fundamentally change treatment outcomes. Rather, studies of opioid, corticotropin-releasing factor, GABA and serotonin systems suggest that incremental advances in treatment outcomes will result from an improved understanding of the genetic heterogeneity among patients with alcohol addiction, and the development of personalized treatments.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available